@article { author = {Motamed, Shadi and Hosseini Karimi, Seyed Nasir and Hooshyar, Mohammadreza and Mehdinavaz Aghdam, Rouhollah}, title = {Advances in nanocarriers as drug delivery systems in Atherosclerosis therapy}, journal = {Journal of Ultrafine Grained and Nanostructured Materials}, volume = {54}, number = {2}, pages = {198-210}, year = {2021}, publisher = {University of Tehran}, issn = {2423-6845}, eissn = {2423-6837}, doi = {10.22059/jufgnsm.2021.02.09}, abstract = {Cardiovascular diseases (CVDs) are known as killer diseases and to overcome these diseases, novel approaches are needed. Although many approaches were able to control this disease, they still had high risks for the patients. One of the best ways to control CVDs is to use targeted Nanosystems, with the help of Nanotechnology and Biology Sciences. Despite current therapeutic strategies to reduce risk, patients still experience the consequences of CVD. Improve visualization of early atherosclerotic lesions to decrease residual CVD risk is one of its goals. Nanomaterials used as Nanocarriers are mainly Polymeric based, Magnetic, Metalic, Silica based and Liposomes. In addition, some drugs can be loaded to these Nanocarries. In this review, we focused on nanocarriers to manage Atherosclerosis, which is the most prevalent type of CVD. We divided these nanocarriers into five main groups: Polymeric nanocarriers, Magnetic nanocarriers, Metalic nanocarriers, Liposomes and Silica-based nanocarriers.}, keywords = {Atherosclerosis,Targeted therapy,Nanocarriers,Polymeric nanocarriers,Magnetic nanocarriers}, url = {https://jufgnsm.ut.ac.ir/article_85176.html}, eprint = {https://jufgnsm.ut.ac.ir/article_85176_d736f739f41d00c8759d95c8282dbfce.pdf} }